259 related articles for article (PubMed ID: 25994164)
21. Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia.
Reddy P; Malczynski M; Obias A; Reiner S; Jin N; Huang J; Noskin GA; Zembower T
Clin Infect Dis; 2007 Oct; 45(7):846-52. PubMed ID: 17806048
[TBL] [Abstract][Full Text] [Related]
22. A multinational study of colonization with extended spectrum β-lactamase-producing Enterobacteriaceae in healthcare personnel and family members of carrier patients hospitalized in rehabilitation centres.
Adler A; Baraniak A; Izdebski R; Fiett J; Salvia A; Samso JV; Lawrence C; Solomon J; Paul M; Lerman Y; Schwartzberg Y; Mordechai E; Rossini A; Fierro J; Lammens C; Malhotra-Kumar S; Goossens H; Hryniewicz W; Brun-Buisson C; Gniadkowski M; Carmeli Y;
Clin Microbiol Infect; 2014 Aug; 20(8):O516-23. PubMed ID: 24450778
[TBL] [Abstract][Full Text] [Related]
23. Comparison of rates of fecal colonization with extended-spectrum beta-lactamase-producing enterobacteria among patients in different wards, outpatients and medical students.
Ebrahimi F; Mózes J; Monostori J; Gorácz O; Fésűs A; Majoros L; Szarka K; Kardos G
Microbiol Immunol; 2016 May; 60(5):285-94. PubMed ID: 26959958
[TBL] [Abstract][Full Text] [Related]
24. Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae carriage at admission in an infant cohort at a tertiary teaching hospital in France.
Rivard-Yazigi L; Zahar JR; Le Guillou S; Chalouhi C; Lecuyer H; Bureau C; Nassif X; Gendrel D; Abadie V
Am J Infect Control; 2013 Sep; 41(9):844-5. PubMed ID: 23465604
[TBL] [Abstract][Full Text] [Related]
25. Background prevalence of extended-spectrum β-lactamase-producing Enterobacteriaceae in the Auckland community.
Upton A; Eyres S; Heffernan H; Taylor S
N Z Med J; 2011 Apr; 124(1332):102-4. PubMed ID: 21747434
[No Abstract] [Full Text] [Related]
26. Prevalence and risk factors for carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae among patients prior to bowel surgery.
Pfeffer I; Zemel M; Kariv Y; Mishali H; Adler A; Braun T; Klein A; Matalon MK; Klausner J; Carmeli Y; Schwaber MJ
Diagn Microbiol Infect Dis; 2016 Jul; 85(3):377-380. PubMed ID: 27133560
[TBL] [Abstract][Full Text] [Related]
27. High burden of extended-spectrum β-lactamase-producing Enterobacteriaceae in Gabon.
Schaumburg F; Alabi A; Kokou C; Grobusch MP; Köck R; Kaba H; Becker K; Adegnika AA; Kremsner PG; Peters G; Mellmann A
J Antimicrob Chemother; 2013 Sep; 68(9):2140-3. PubMed ID: 23645586
[TBL] [Abstract][Full Text] [Related]
28. Multicentre evaluation of the Check-Direct CPE® assay for direct screening of carbapenemase-producing Enterobacteriaceae from rectal swabs.
Huang TD; Bogaerts P; Ghilani E; Heinrichs A; Gavage P; Roisin S; Willems E; Verbruggen AM; Francart H; Denis O; Senterre JM; Glupczynski Y
J Antimicrob Chemother; 2015; 70(6):1669-73. PubMed ID: 25637518
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of and risk factors associated with faecal carriage of CTX-M β-lactamase-producing Enterobacteriaceae in rural Thai communities.
Luvsansharav UO; Hirai I; Nakata A; Imura K; Yamauchi K; Niki M; Komalamisra C; Kusolsuk T; Yamamoto Y
J Antimicrob Chemother; 2012 Jul; 67(7):1769-74. PubMed ID: 22514260
[TBL] [Abstract][Full Text] [Related]
30. New screening method to detect carriage of carbapenemase-producing Enterobacteriaceae in patients within 24 hours.
Hanemaaijer NM; Nijhuis RH; Slotboom BJ; Mascini EM; van Zwet AA
J Hosp Infect; 2014 May; 87(1):47-9. PubMed ID: 24746789
[TBL] [Abstract][Full Text] [Related]
31. Decolonization of intestinal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial.
Huttner B; Haustein T; Uçkay I; Renzi G; Stewardson A; Schaerrer D; Agostinho A; Andremont A; Schrenzel J; Pittet D; Harbarth S
J Antimicrob Chemother; 2013 Oct; 68(10):2375-82. PubMed ID: 23719234
[TBL] [Abstract][Full Text] [Related]
32. Carbapenemase-producing Enterobacteriaceae in Irish critical care units: results of a pilot prevalence survey, June 2011.
Burns K; Morris D; Murchan S; Cunney R; Smyth E; Power M; Schaffer K; Collins C; Sheahan A; Cormican M; Fitzpatrick F
J Hosp Infect; 2013 Jan; 83(1):71-3. PubMed ID: 23149057
[TBL] [Abstract][Full Text] [Related]
33. Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae is common 12 months after infection and is related to strain factors.
Titelman E; Hasan CM; Iversen A; Nauclér P; Kais M; Kalin M; Giske CG
Clin Microbiol Infect; 2014 Aug; 20(8):O508-15. PubMed ID: 24450760
[TBL] [Abstract][Full Text] [Related]
34. Assessment of five screening strategies for optimal detection of carriers of third-generation cephalosporin-resistant Enterobacteriaceae in intensive care units using daily sampling.
Grohs P; Podglajen I; Guerot E; Bellenfant F; Caumont-Prim A; Kac G; Tillecovidin B; Carbonnelle E; Chatellier G; Meyer G; Fagon JY; Gutmann L
Clin Microbiol Infect; 2014 Nov; 20(11):O879-86. PubMed ID: 24807791
[TBL] [Abstract][Full Text] [Related]
35. Universal hospital admission screening for carbapenemase-producing organisms in a low-prevalence setting.
Otter JA; Dyakova E; Bisnauthsing KN; Querol-Rubiera A; Patel A; Ahanonu C; Tosas Auguet O; Edgeworth JD; Goldenberg SD
J Antimicrob Chemother; 2016 Dec; 71(12):3556-3561. PubMed ID: 27516471
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of carriage of extended-spectrum β-lactamase-producing enterobacteria and associated factors in a French hospital.
Jolivet S; Vaillant L; Poncin T; Lolom I; Gaudonnet Y; Rondinaud E; Bendjelloul G; Lomont A; Lucet JC; Armand-Lefèvre L
Clin Microbiol Infect; 2018 Dec; 24(12):1311-1314. PubMed ID: 29549056
[TBL] [Abstract][Full Text] [Related]
37. High carriage rate of extended-spectrum beta-lactamase-producing Enterobacteriaceae among patients admitted for surgery in Tanzanian hospitals with a low rate of endogenous surgical site infections.
Moremi N; Claus H; Rutta L; Frosch M; Vogel U; Mshana SE
J Hosp Infect; 2018 Sep; 100(1):47-53. PubMed ID: 29852267
[TBL] [Abstract][Full Text] [Related]
38. Individual- and community-level risk factors for ESBL Enterobacteriaceae colonization identified by universal admission screening in London.
Otter JA; Natale A; Batra R; Tosas Auguet O; Dyakova E; Goldenberg SD; Edgeworth JD
Clin Microbiol Infect; 2019 Oct; 25(10):1259-1265. PubMed ID: 30849431
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for carbapenemase-producing Enterobacteriaceae colonization of asymptomatic carriers on admission to an Italian rehabilitation hospital.
Rossini A; Di Santo SG; Libori MF; Tiracchia V; Balice MP; Salvia A
J Hosp Infect; 2016 Jan; 92(1):78-81. PubMed ID: 26615459
[TBL] [Abstract][Full Text] [Related]
40. Risk factors of fecal carriage with extended-spectrum β-lactamase-producing Enterobacteriaceae in hospitalized patients.
Ko YJ; Moon HW; Hur M; Yun YM
Am J Infect Control; 2013 Dec; 41(12):1241-3. PubMed ID: 23969111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
